D8 (RBOT)
(Delayed Data from NYSE)
$5.84 USD
+0.63 (12.09%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $5.76 -0.08 (-1.37%) 5:44 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Top 35% (88 out of 251)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.50 | 1.69 | 9.99 |
Current Quarter Estimate | -2.61 | 3.68 | 61.00 |
Year Ago Quarter Estimate | -3.60 | 3.17 | 54.84 |
Next Quarter Estimate | -2.52 | 4.86 | 63.00 |
Next Year Estimate | -8.26 | 24.53 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 36.36 | 12.10 | 15.67 |
Next Year | 16.90 | 21.90 | 11.34 |
Last 5 Years | NA | 10.20 | 8.10 |
Next 5 Years | NA | 13.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 0.97 |
Price/Book (MRQ) | 0.43 | 2.24 |
Price/Cash Flow (MRFY) | NA | 17.27 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -14.98% |
Return on Equity (TTM) | -74.02% | -6.51% |
Debt to Equity (MRQ) | 0.00 | 19.41 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.